462 related articles for article (PubMed ID: 17949407)
41. Lymphocytes, chronic bronchitis and chronic obstructive pulmonary disease.
Jeffery PK
Novartis Found Symp; 2001; 234():149-61; discussion 161-8. PubMed ID: 11199094
[TBL] [Abstract][Full Text] [Related]
42. Functional and molecular characterization of a KIR3DL2/p140 expressing tumor-specific cytotoxic T lymphocyte clone infiltrating a human lung carcinoma.
Dorothée G; Echchakir H; Le Maux Chansac B; Vergnon I; El Hage F; Moretta A; Bensussan A; Chouaib S; Mami-Chouaib F
Oncogene; 2003 Oct; 22(46):7192-8. PubMed ID: 14562047
[TBL] [Abstract][Full Text] [Related]
43. CD4+/CD25+ cells in systemic inflammation in COPD.
Domagała-Kulawik J; Hoser G; Dąbrowska M; Safianowska A; Chazan R
Scand J Immunol; 2011 Jan; 73(1):59-65. PubMed ID: 21129004
[TBL] [Abstract][Full Text] [Related]
44. Distribution of γδ and other T-lymphocyte subsets in patients with chronic obstructive pulmonary disease and asthma.
Urboniene D; Babusyte A; Lötvall J; Sakalauskas R; Sitkauskiene B
Respir Med; 2013 Mar; 107(3):413-23. PubMed ID: 23273406
[TBL] [Abstract][Full Text] [Related]
45. Imbalance between subpopulations of regulatory T cells in COPD.
Hou J; Sun Y; Hao Y; Zhuo J; Liu X; Bai P; Han J; Zheng X; Zeng H
Thorax; 2013 Dec; 68(12):1131-9. PubMed ID: 23749814
[TBL] [Abstract][Full Text] [Related]
46. Long-term surgical outcome in patients with lung cancer and coexisting severe COPD.
Nakajima T; Sekine Y; Yamada Y; Suzuki H; Yasufuku K; Yoshida S; Suzuki M; Shibuya K; Fujisawa T; Yoshino I
Thorac Cardiovasc Surg; 2009 Sep; 57(6):339-42. PubMed ID: 19707975
[TBL] [Abstract][Full Text] [Related]
47. Lymphocyte subpopulations anomalies in lung cancer patients and relationship to the stage of disease.
Mazzoccoli G; Balzanelli M; Giuliani A; De Cata A; La Viola M; Carella AM; Bianco G; Tarquini R
In Vivo; 1999; 13(3):205-9. PubMed ID: 10459492
[TBL] [Abstract][Full Text] [Related]
48. Sputum T lymphocytes in asthma, COPD and healthy subjects have the phenotype of activated intraepithelial T cells (CD69+ CD103+).
Leckie MJ; Jenkins GR; Khan J; Smith SJ; Walker C; Barnes PJ; Hansel TT
Thorax; 2003 Jan; 58(1):23-9. PubMed ID: 12511714
[TBL] [Abstract][Full Text] [Related]
49. Functional Heterogeneity of CD4
Oja AE; Piet B; van der Zwan D; Blaauwgeers H; Mensink M; de Kivit S; Borst J; Nolte MA; van Lier RAW; Stark R; Hombrink P
Front Immunol; 2018; 9():2654. PubMed ID: 30505306
[TBL] [Abstract][Full Text] [Related]
50. Stromal CD4/CD25 positive T-cells are a strong and independent prognostic factor in non-small cell lung cancer patients, especially with adenocarcinomas.
Kayser G; Schulte-Uentrop L; Sienel W; Werner M; Fisch P; Passlick B; Zur Hausen A; Stremmel C
Lung Cancer; 2012 Jun; 76(3):445-51. PubMed ID: 22300751
[TBL] [Abstract][Full Text] [Related]
51. Differing phenotypes between intraepithelial and stromal lymphocytes in early-stage tongue cancer.
Katou F; Ohtani H; Watanabe Y; Nakayama T; Yoshie O; Hashimoto K
Cancer Res; 2007 Dec; 67(23):11195-201. PubMed ID: 18056444
[TBL] [Abstract][Full Text] [Related]
52. COPD increases the risk of squamous histological subtype in smokers who develop non-small cell lung carcinoma.
Papi A; Casoni G; Caramori G; Guzzinati I; Boschetto P; Ravenna F; Calia N; Petruzzelli S; Corbetta L; Cavallesco G; Forini E; Saetta M; Ciaccia A; Fabbri LM
Thorax; 2004 Aug; 59(8):679-81. PubMed ID: 15282388
[TBL] [Abstract][Full Text] [Related]
53. A novel insight into adaptive immunity in chronic obstructive pulmonary disease: B cell activating factor belonging to the tumor necrosis factor family.
Polverino F; Baraldo S; Bazzan E; Agostini S; Turato G; Lunardi F; Balestro E; Damin M; Papi A; Maestrelli P; Calabrese F; Saetta M
Am J Respir Crit Care Med; 2010 Oct; 182(8):1011-9. PubMed ID: 20581172
[TBL] [Abstract][Full Text] [Related]
54. Identification of CD8+CD25+Foxp3+ suppressive T cells in colorectal cancer tissue.
Chaput N; Louafi S; Bardier A; Charlotte F; Vaillant JC; Ménégaux F; Rosenzwajg M; Lemoine F; Klatzmann D; Taieb J
Gut; 2009 Apr; 58(4):520-9. PubMed ID: 19022917
[TBL] [Abstract][Full Text] [Related]
55. Exercise capacity after lobectomy in patients with chronic obstructive pulmonary disease.
Kushibe K; Kawaguchi T; Kimura M; Takahama M; Tojo T; Taniguchi S
Interact Cardiovasc Thorac Surg; 2008 May; 7(3):398-401. PubMed ID: 18270219
[TBL] [Abstract][Full Text] [Related]
56. Expression of macrophage surface markers in induced sputum of patients with chronic obstructive pulmonary disease.
Domagała-Kulawik J; Maskey-Warzechowska M; Hermanowicz-Salamon J; Chazan R
J Physiol Pharmacol; 2006 Sep; 57 Suppl 4():75-84. PubMed ID: 17072032
[TBL] [Abstract][Full Text] [Related]
57. Characterization of the interstitial lung and peripheral blood T cell receptor repertoire in cigarette smokers.
Korn S; Wiewrodt R; Walz YC; Becker K; Mayer E; Krummenauer F; Buhl R
Am J Respir Cell Mol Biol; 2005 Feb; 32(2):142-8. PubMed ID: 15539458
[TBL] [Abstract][Full Text] [Related]
58. Measurement of soluble perforin, a marker of CD8+ T lymphocyte activation in epithelial lining fluid.
Shiratsuchi N; Asai K; Kanazawa H; Kyoh S; Tochino Y; Kodama T; Hirata K
Respir Med; 2011 Dec; 105(12):1885-90. PubMed ID: 21827966
[TBL] [Abstract][Full Text] [Related]
59. Tenascin-C, over expressed in lung cancer down regulates effector functions of tumor infiltrating lymphocytes.
Parekh K; Ramachandran S; Cooper J; Bigner D; Patterson A; Mohanakumar T
Lung Cancer; 2005 Jan; 47(1):17-29. PubMed ID: 15603851
[TBL] [Abstract][Full Text] [Related]
60. The expression of Foxp3 and ROR gamma t in lung tissues from normal smokers and chronic obstructive pulmonary disease patients.
Chu S; Zhong X; Zhang J; Lao Q; He Z; Bai J
Int Immunopharmacol; 2011 Nov; 11(11):1780-8. PubMed ID: 21791252
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
